Cambiar Investors LLC Nuvasive Inc Transaction History

Cambiar Investors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$36.71 - $44.15 $203,043 - $244,193	-5,531 Reduced 11.8%	41,348 $1.72 Million
Q1 2023 May 08, 2023	BUY	$36.81 - $48.12 $368 - $481	10 Added 0.02%	46,879 $1.94 Million
Q4 2022 Feb 02, 2023	BUY	$35.68 - $44.71 $455,526 - $570,812	12,767 Added 37.44%	46,869 $1.93 Million
Q3 2022 Oct 28, 2022	SELL	$42.51 - $54.02 $16,238 - $20,635	-382 Reduced 1.11%	34,102 $1.49 Million
Q2 2022 Aug 05, 2022	SELL	$46.84 - $59.75 $342,540 - $436,951	-7,313 Reduced 17.5%	34,484 $1.7 Million

Q1 2022 Apr 28, 2022	SELL	$48.09 - $57.79 $90,457 - $108,702	-1,881 Reduced 4.31%	41,797 $2.37 Million
Q4 2021 Jan 27, 2022	SELL	$47.19 - $62.68 $172,243 - $228,782	-3,650 Reduced 7.71%	43,678 $2.29 Million
Q3 2021 Oct 22, 2021	SELL	$56.91 - $67.81 $40,804 - $48,619	-717 Reduced 1.49%	47,328 $2.83 Million
Q2 2021 Aug 02, 2021	BUY	$64.02 - $71.72 $54,288 - $60,818	848 Added 1.8%	48,045 $3.26 Million
Q1 2021 May 14, 2021	BUY	$53.26 - $68.08 $2.51 Million - $3.21 Million	47,197 New	47,197 $3.09 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Cambiar Investors LLC with notifications on news.